Advertisement

Index by author

July 01, 1993; Volume 266,Issue 1

  1. Kobayashi, K

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  2. Kohara, Y

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  3. Kohsaka, M

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;

  4. Kopin, I J

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;

  5. Kramer, R E

    1. Effects of diltiazem on calcium metabolism in cultured bovine glomerulosa cells: relationships to the actions of angiotensin II and potassium.
      R E Kramer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 374-384;

  6. Kreppel, H

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  7. Kubo, K

    1. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
      H Mizumoto, A Karasawa and K Kubo
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 200-206;
    2. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  8. Kvetnansky, R

    1. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
      J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;
« Previous (Pages : 1 2 ... 2)next »
Back to top

In this issue

Advertisement